Status:
COMPLETED
Paracetamol and Pharmacogenetic
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Healthy
Eligibility:
MALE
18-30 years
Phase:
PHASE1
Brief Summary
Recent works has emphasized that the mechanism of action of paracetamol analgesic depend on its metabolism in the body, since a breakdown product of paracetamol, the AM404 is now considered the analge...
Detailed Description
Randomized, single-center, placebo-controlled, double-blind, cross-over in 100 healthy volunteers meeting the inclusion criteria and receiving 2g of paracetamol orally or placebo on two study periods ...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Males
- Aged between 18 and 30 years
Exclusion
- Subject without cons-indications of paracetamol
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01520792
Start Date
November 1 2011
End Date
May 1 2013
Last Update
May 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003